Company profile
Ray Therapeutics, Inc.
Optogenetic Gene Therapy Company
- Industry
- Biotechnology Research
- Employees
- 45
- Headquarters
- Berkeley, California
- Founded
- 2021
- LinkedIn followers
- 8,014
- Office locations
- 1
Ray Therapeutics, Inc. company summary
Ray Therapeutics, Inc. is a company in the Biotechnology Research industry, headquartered in Berkeley, California, founded in 2021. On LinkedIn the company has around 45 employees and 8,014 followers.
What technology does Ray Therapeutics, Inc. use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Ray Therapeutics, Inc.
Founded in 2021, Ray Therapeutics is a clinical-stage biotechnology company developing best-in-class vision restoration therapies for people with degenerative retinal diseases independent of genetic mutation. We use the innovative technology of optogenetics to reprogram surviving neurons in the retina of the eye to sense light and send visual signals to the brain—restoring vision. We are advancing our pipeline of optogenetic medicines to address a range of degenerative retinal diseases, with programs in both preclinical and clinical stages of development. Ray Therapeutics’ lead candidate, RTX-015, is bioengineered to repurpose retinal ganglion cells to restore vision, and is being evaluated in a Phase 1 trial in Retinitis Pigmentosa and Choroideremia.
Where is Ray Therapeutics, Inc. located?
Ray Therapeutics, Inc. lists 1 location.
Compare companies similar to Ray Therapeutics, Inc.
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Ray Therapeutics, Inc. raytherapeutics.com | Biotechnology Research | 45 | 2021 | Berkeley, California |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Ray Therapeutics, Inc.
What does Ray Therapeutics, Inc. do?
Founded in 2021, Ray Therapeutics is a clinical-stage biotechnology company developing best-in-class vision restoration therapies for people with degenerative retinal diseases independent of genetic mutation. We use the innovative technology of optogenetics to reprogram surviving neurons in the retina of the eye to sense light and send visual signals to the brain—restoring vision. We are advancing our pipeline of optogenetic medicines to address a range of degenerative retinal diseases, with programs in both preclinical and clinical stages of development. Ray Therapeutics’ lead candidate, RTX-015, is bioengineered to repurpose retinal ganglion cells to restore vision, and is being evaluated in a Phase 1 trial in Retinitis Pigmentosa and Choroideremia.
How many employees does Ray Therapeutics, Inc. have?
Ray Therapeutics, Inc. has around 45 employees on LinkedIn.
Where is Ray Therapeutics, Inc. headquartered?
Ray Therapeutics, Inc. is headquartered in Berkeley, California.
When was Ray Therapeutics, Inc. founded?
Ray Therapeutics, Inc. was founded in 2021.
Build a lead list from companies like Ray Therapeutics, Inc.
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.